Drawing for BEGINNING TO END

USPTO serial 79206555

BEGINNING TO END

Reviewed by CopyMark Law Group

Reg. 5393500Status 709
Filing date
Status date
Registration date
Feb 6, 2018
Examiner
MANOR, THOMAS M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BEGINNING TO END?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Shoko Naruo

Shoko Naruo Thompson Coburn LLPOne US Bank PlazaSt. Louis, MO 63101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical diagnostic preparations for scientific or research use; chemicals for use in histological and cytological tissue processing, namely, fixative and dehydrant; chemical reagents, for laboratory use, not for medical or veterinary purposes; reagents for use in genetic research; diagnostic preparations containing antibodies for scientific or laboratory use; none of the foregoing being for medical or veterinary use; histology and cytology reagents and stains for preparation of pathology tissue specimens for research purposesSECTION 71 - CANCELLED—
005Histology and cytology reagents and stains for preparation of pathology tissue specimens for medical purposes; pharmaceutical preparations for histological and cytological tissue processing applications; pharmaceutical preparations, namely, antibodies for the treatment of cancer; reagents for medical, diagnostic, or veterinary purposes; medical preparations in the nature of epitope retrieval solutions; digestive enzymes and enzyme preparations for medical and diagnostic purposes; diagnostic histological dye and stain solutions; double, triple, or multiple immuno-histochemical staining reagents; double, triple or multiple in situ hybridisation application of multiple antibodies or probes in the same staining procedure to a tissue section during IHC staining for medical or veterinary purposes; diagnostic kits for processing, embedding and staining histological tissues consisting primarily of monoclonal or polyclonal antibodiesSECTION 71 - CANCELLED—
009Scientific apparatus and equipment, namely, scientific laboratory workstations and associated computer software used for protein, nucleic acid or immunoassay analysis in the fields of in-vitro diagnostics and biomedical diagnosis; computer operated automation systems comprised of computer hardware and operating software for laboratory instruments; laboratory instruments for specimen preparation; automated immunostainers for laboratory use; laboratory equipment for use in specimen preparation, namely, tissue processors; haematology slide makers and stainers for placing a barrier on a slide for use in scientific research; clinical chemistry instruments for laboratory use, namely, clinical chemistry analyzers; random access clinical chemistry analysers for the analysis of biological samples for scientific research purposes; immunoassay clinical analysers; histopathology instruments, tissue processors and haematology instruments used in scientific research for processing biological samples; laboratory devices for histology and cytology, namely, coverslipping machines for slides, tissue infiltration apparatus, tissue embedding machines, staining machines, staining machines with immunological responses; tissue processors for processing biological samples for laboratory use; multiwell plates for use in chemical analysis and laboratory or medical research use; cryostats for laboratory use; cryomacrotomes for laboratory use; automatic slide scanners; laboratory equipment and supplies for collecting, preparing, holding and filing of histological and cytological specimens for microscopic, magnetic resonance, tomosynthesis, ultra-sound or x-ray examination, namely, sample containers, specimen containers, sample cassettes, biopsy cassettes; label printer for printing labels for sample cassettes and biopsy cassettes; barcode reader for reading the printed labels on sample cassettes and biopsy cassettes; x-ray, magnetic resonance, tomosynthesis, ultrasound or microscope-based devices for examining tissue samples; software for tracking the location of histological and cytological specimens; microtomes and microtome blades for use in histology lab; ultramicrotomes and ultramicrome blades, diamond knives, glass knives, glass breaker for preparing glass knives for laboratory use; tissue cutting tools and micro and macro tissue grossing stations for laboratory use; fume hoods for specimen preparation for laboratory use; microscopic slides and cover glass; specimen embedding cassettes for laboratory use; specimen embedding stations for laboratory use; slide and specimen cassette electric printers; image analysis devices, namely, scanners for laboratory use; electronic image recording, image storing and image representing devices, namely, digital cameras; reading devices and writing devices for codes of multiwell plates, cassettes, slides, sample carriers, namely, bar-code scanners, storing and transporting devices, namely, blank hard drives for computers; computer operating software for image analysis and image storage devices, namely, digital cameras for laboratory use; software operating for histological and cytological scientific and diagnostic apparatus and laboratory equipment; computer software for digitizing microscope slides for viewing, integration with other data, management, and analysis, all in the fields of virtual microscopy, digital pathology, digital hematology and medical information technology; automated digital scanning system integrating optical microscopy, motorized sample positioning, digital image capture, data processing, manipulation and display for use in scanning and digitizing microscope samples in research and clinical environments; digital slide information management software for digitizing entire glass microscope slides into diagnostic quality images displayed in context with reports, case histories and other associated documents, cross-linked and concurrently viewable for use in the fields of virtual microscopy, digital pathology, digital hematology and medical information technologySECTION 71 - CANCELLED—
010Medical apparatus, namely, histopathology instruments, tissue processors and haematology instruments for clinical purposes, namely, tissue staining instruments for staining, diagnostic medical apparatus and instruments, namely, diagnostic medical apparatus for performing Immuno-histochemistry and In situ-hybridisation staining reactions, and histological and pathological staining; DNA in situ hybridisation probes; diagnostic medical apparatus for promoting and controlling reaction on microarrays or under slide covers; medical instruments, needles, probes, and devices for the purpose of tissue biopsy or tissue removal from glands and/or organs in the human body; surgical device, namely, a vacuum used in breast biopsies; biopsy site markers; x-ray, magnetic resonance, tomosynthesis, ultrasound or microscope-based devices for examining tissue samples for medical purposesSECTION 71 - CANCELLED—
037Maintenance and repair of scientific apparatus and equipment; maintenance and repair of pathology and clinical laboratory apparatus; maintenance and repair of computer operated automation systems for laboratory instruments; maintenance and repair of scientific, fine mechanical, optical, electronic apparatuses and devicesSECTION 71 - CANCELLED—
042Scientific and technological services and research and design, namely, research and design in the field of testing, analyzing, examining or storing biological samples, medical samples, and cell samples; industrial analysis and research services namely, scientific research services for medical purposes, laboratory biological research, clinical biological research, biological research and research relating to the testing of biological samples, medical samples, and cell samples; creation of computer programs for the data processing of scientific, optical and electronic apparatuses and devices; creation of computer programs for use in providing data processing for scientific, diagnostic, research or laboratory purposes for use in microtomes, ultramicrotomes, cryomicrotomes, cryostats, macrotomes, cryomacrotomes, telepathology devices, automatic slide scanners; creation of computer programs for use in providing data processing for scientific, diagnostic, research or laboratory purposes for use in laboratory devices for histology and cytology, namely, coverslipping machines for slides, tissue infiltration devices, tissue embedding machines, staining machines, staining machines with immunological responses, contrasting machines, glass knife breakers, high-pressure freezing devices for microscopic sample preparation, and sample carriers for microscopic preparations; scientific consultation, namely, technical advice for scientific and medical institutions with respect to the application of scientific, diagnostic, research and laboratory optical and electronic apparatuses and devices, not to include medical consultations; maintenance and repair of computer operating software for image analysis and image storage devicesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 22, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Aug 3, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 3, 2025INPCINVALIDATION PROCESSED—
Apr 23, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 23, 2024C71TCANCELLED SECTION 71—
Jul 7, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 6, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 28, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 28, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 28, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 28, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 28, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 15, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 15, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 15, 2018FIMPFINAL DISPOSITION PROCESSED—
May 6, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 6, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 21, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 21, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 1, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 10, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 10, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Oct 10, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 10, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 10, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 6, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 6, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 6, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 3, 2017RFNTREFUSAL PROCESSED BY IB—
May 18, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 18, 2017RFRRREFUSAL PROCESSED BY MPU—
May 11, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 10, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 9, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
May 5, 2017DOCKASSIGNED TO EXAMINER—
May 5, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 4, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance